Stockreport

60 Degrees Pharmaceuticals Announces 2025 Annual Results

60 Degrees Pharmaceuticals, Inc.  (SXTP) 
PDF FY 2025 net product revenues increased 65% to $1,005,000Current shelf capacity exhausted after raise of $4 million through an ATM facility WASHINGTON, March 31, 2026 [Read more]